company background image
CSX

CleanSpace HoldingsASX:CSX Stock Report

Last Price

AU$1.48

Market Cap

AU$114.0m

7D

5.7%

1Y

-78.6%

Updated

20 Jan, 2022

Data

Company Financials +
CSX fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance6/6
Financial Health5/6
Dividends0/6

CSX Stock Overview

CleanSpace Holdings Limited engages in the design, manufacture, and sale of respirators and related products and services for healthcare and industrial employers worldwide.

Price History & Performance

Summary of all time highs, changes and price drops for CleanSpace Holdings
Historical stock prices
Current Share PriceAU$1.48
52 Week HighAU$7.37
52 Week LowAU$1.30
Beta0
1 Month Change9.63%
3 Month Change-14.45%
1 Year Change-78.55%
3 Year Changen/a
5 Year Changen/a
Change since IPO-80.05%

Recent News & Updates

Nov 29
CleanSpace Holdings (ASX:CSX) Is Achieving High Returns On Its Capital

CleanSpace Holdings (ASX:CSX) Is Achieving High Returns On Its Capital

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...

Oct 21
CleanSpace Holdings Limited's (ASX:CSX) Shares Leap 25% Yet They're Still Not Telling The Full Story

CleanSpace Holdings Limited's (ASX:CSX) Shares Leap 25% Yet They're Still Not Telling The Full Story

CleanSpace Holdings Limited ( ASX:CSX ) shareholders would be excited to see that the share price has had a great...

Shareholder Returns

CSXAU Medical EquipmentAU Market
7D5.7%-4.1%-1.7%
1Y-78.6%-10.9%7.7%

Return vs Industry: CSX underperformed the Australian Medical Equipment industry which returned -10.9% over the past year.

Return vs Market: CSX underperformed the Australian Market which returned 7.7% over the past year.

Price Volatility

Is CSX's price volatile compared to industry and market?
CSX volatility
CSX Average Weekly Movement6.9%
Medical Equipment Industry Average Movement8.7%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.3%
10% least volatile stocks in AU Market3.6%

Stable Share Price: CSX is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: CSX's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2009n/aAlex Birrellhttps://www.cleanspacetechnology.com

CleanSpace Holdings Limited engages in the design, manufacture, and sale of respirators and related products and services for healthcare and industrial employers worldwide. It offers CleanSpace HALO, a personal respiratory protection for healthcare; CleanSpace ULTRA, a personal respiratory protection for face/eye protection and water tolerance; CleanSpace2, a personal respiratory protection for workers in general industrial environments; and CleanSpace EX for personal protection for people working in explosive environments. The company also provides accessories and consumable products comprising masks, filters, docking stations, cleaning and storage products, car charger, biohoods, half mask and bio mask exhalation adaptors, unit id panels, mask id badges, mask decal, helmet hook strap, hoods, backpacks, full face mask quantitative fit test, full face mask spectacle kit, visor protectors, head harness, grommet, and spares.

CleanSpace Holdings Fundamentals Summary

How do CleanSpace Holdings's earnings and revenue compare to its market cap?
CSX fundamental statistics
Market CapAU$113.99m
Earnings (TTM)AU$11.39m
Revenue (TTM)AU$49.93m

10.0x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CSX income statement (TTM)
RevenueAU$49.93m
Cost of RevenueAU$11.54m
Gross ProfitAU$38.38m
ExpensesAU$26.99m
EarningsAU$11.39m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.15
Gross Margin76.88%
Net Profit Margin22.81%
Debt/Equity Ratio5.8%

How did CSX perform over the long term?

See historical performance and comparison

Valuation

Is CleanSpace Holdings undervalued compared to its fair value and its price relative to the market?

10.01x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate CSX's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate CSX's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: CSX is good value based on its PE Ratio (10x) compared to the Australian Medical Equipment industry average (13.2x).

PE vs Market: CSX is good value based on its PE Ratio (10x) compared to the Australian market (19.3x).


Price to Earnings Growth Ratio

PEG Ratio: CSX's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: CSX is good value based on its PB Ratio (2.8x) compared to the AU Medical Equipment industry average (4.4x).


Future Growth

How is CleanSpace Holdings forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

-61.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CSX's earnings are forecast to decline over the next 3 years (-61.5% per year).

Earnings vs Market: CSX's earnings are forecast to decline over the next 3 years (-61.5% per year).

High Growth Earnings: CSX's earnings are forecast to decline over the next 3 years.

Revenue vs Market: CSX's revenue is expected to decline over the next 3 years (-16.1% per year).

High Growth Revenue: CSX's revenue is forecast to decline over the next 3 years (-16.1% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CSX is forecast to be unprofitable in 3 years.


Past Performance

How has CleanSpace Holdings performed over the past 5 years?

57.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CSX has high quality earnings.

Growing Profit Margin: CSX's current net profit margins (22.8%) are higher than last year (20.8%).


Past Earnings Growth Analysis

Earnings Trend: CSX's earnings have grown significantly by 57.8% per year over the past 5 years.

Accelerating Growth: CSX's earnings growth over the past year (92.3%) exceeds its 5-year average (57.8% per year).

Earnings vs Industry: CSX earnings growth over the past year (92.3%) exceeded the Medical Equipment industry 74.9%.


Return on Equity

High ROE: CSX's Return on Equity (28%) is considered high.


Financial Health

How is CleanSpace Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: CSX's short term assets (A$45.8M) exceed its short term liabilities (A$7.9M).

Long Term Liabilities: CSX's short term assets (A$45.8M) exceed its long term liabilities (A$2.1M).


Debt to Equity History and Analysis

Debt Level: CSX has more cash than its total debt.

Reducing Debt: Insufficient data to determine if CSX's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: CSX's debt is well covered by operating cash flow (567.1%).

Interest Coverage: CSX's interest payments on its debt are well covered by EBIT (237.5x coverage).


Balance Sheet


Dividend

What is CleanSpace Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CSX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CSX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CSX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CSX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CSX's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.0yrs

Average management tenure


CEO

Alex Birrell

8yrs

Tenure

Dr. Alexandra Birrell, also known as Alex, serves as Executive Director and Chief Executive Officer of CleanSpace Holdings Limited since 2015 and 2014 and served as Director. Dr Birrell joined CleanSpace i...


Leadership Team

Experienced Management: CSX's management team is seasoned and experienced (5 years average tenure).


Board Members

Experienced Board: CSX's board of directors are considered experienced (7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

CleanSpace Holdings Limited's employee growth, exchange listings and data sources


Key Information

  • Name: CleanSpace Holdings Limited
  • Ticker: CSX
  • Exchange: ASX
  • Founded: 2009
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: AU$113.989m
  • Shares outstanding: 77.02m
  • Website: https://www.cleanspacetechnology.com

Location

  • CleanSpace Holdings Limited
  • Unit 5
  • 39 Herbert Street
  • St Leonards
  • New South Wales
  • 2065
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/20 16:16
End of Day Share Price2022/01/20 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.